Documenta Ophthalmologica

, Volume 119, Supplement 1, pp 17–92 | Cite as

Abstracts: XLVII ISCEV International Symposium

Abano Terme-Padova, Italy; July 6–10, 2009

Invited Lecture 1: Injecting the eye: neurosensory retinal and intravitreal drugs for degenerative retinal diseases

Professor Edoardo Midena

Department of Ophthalmology, University of Padova, Padova, Italy & Fondazione GB Bietti per l’Oftalmologia, IRCCS, Roma, Italy

The treatment of major degenerative retinal diseases, namely age-related macular degeneration and diabetic retinopathy, is tending towards a pharmacologic approach compared to the previous physical therapy. Systemic treatments have demonstrated more complications than benefits, and so there is an increasing and enthusiastic trend toward direct local (intraocular) therapy. A number of different drugs are currently used or under investigation. Most of these drugs are selective or unselective vascular endothelial growth factor (VEGF) antagonists, because VEGF is considered a key factor in the pathogenesis of intraocular neovascularisation, both retinal and choroidal. VEGF properties also favour hyperpermeability of retinal...

Copyright information

© Springer-Verlag 2009

Personalised recommendations